Protalix Biotherapeutics Inc
פרוטליקס ביות'רפיוטיקס אינק · limited company
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 55 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
0
confidence 70 % · metrics-v1
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 67 % · cci-v1
11 active sensors·1 observation·0 historical changes·0 structured events·historical coverage 90 %·observed since 2026-09-13
Compare Protalix Biotherapeutics Inc with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies